Compass Pathways Plc (CMPS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CMPS SEC filings page.
This page shows Compass Pathways Plc (CMPS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A research-heavy cost base is consuming cash, while fresh financing has not prevented rapid deterioration in short-term balance-sheet capacity.
Operating loss was essentially flat, moving from-$178.2M in FY2024 to-$179.0M in FY2025, so the core spending burden stopped worsening at the same pace. Yet net loss widened to-$269.8M while operating cash flow was-$157.2M , showing that reported earnings were affected by a much larger below-operating-income gap than the cash operating requirement alone.
Equity moved from
R&D was
Financial Health Signals
Compass Pathways Plc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Compass Pathways Plc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
Compass Pathways Plc reported a net loss of $269.8M while operations used $157.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Compass Pathways Plc reported an operating loss of $179.0M against $4.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Compass Pathways Plc's EBITDA was -$52.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 22.4% from the same quarter a year earlier. Against the prior quarter it is down 22.1%.
Compass Pathways Plc reported -$253.8M in net income in Q2 2026. This represents a decrease of 560.9% from the same quarter a year earlier. Against the prior quarter it is down 378.3%.
Compass Pathways Plc earned -$1.88 per diluted share (EPS) in Q2 2026. This represents a decrease of 358.5% from the same quarter a year earlier. Against the prior quarter it is down 526.7%.
Not reported for Q2 2026.
Cash & Balance Sheet
Compass Pathways Plc held $433.3M in cash against $50.7M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Compass Pathways Plc's ROE was -300.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 276.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 328.1 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Compass Pathways Plc invested $29.2M in research and development in Q2 2026. This represents a decrease of 3.8% from the same quarter a year earlier. Against the prior quarter it is up 10.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CMPS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $29.2M-3.8% | $26.5M-14.2% | N/A | $27.3M-17.0% | $30.3M+4.3% | $30.9M+24.0% | N/A | $32.9M+53.0% |
| SG&A Expenses | $23.2M+84.0% | $16.4M-12.3% | N/A | $13.2M-11.7% | $12.6M-11.5% | $18.7M+37.0% | N/A | $15.0M+19.4% |
| Operating Income | -$52.4M-22.0% | -$42.9M+13.5% | N/A | -$40.5M+15.4% | -$42.9M+0.9% | -$49.6M-28.6% | N/A | -$47.9M-40.6% |
| EBITDA | -$52.4M-22.4% | -$42.9M+13.5% | N/A | -$40.5M+15.3% | -$42.8M | -$49.6M-28.7% | N/A | -$47.8M-41.2% |
| Interest Expense | $1.5M+28.8% | $1.5M+66.7% | N/A | $1.1M-2.8% | $1.2M+3.5% | $900K-18.0% | N/A | $1.1M+5.3% |
| Income Tax | $331K+141.6% | -$11K-103.1% | N/A | -$230K-232.9% | $137K-22.2% | $354K+59.5% | N/A | $173K+179.0% |
| Net Income | -$253.8M-560.9% | $91.2M+610.5% | N/A | -$137.7M-257.7% | -$38.4M-0.8% | -$17.9M+49.2% | N/A | -$38.5M-15.3% |
| EPS (Basic) | -$1.88-358.5% | $0.71+455.0% | -$0.99-57.1% | -$1.44-157.1% | -$0.41+26.8% | -$0.20+63.6% | -$0.63-23.5% | -$0.56+16.4% |
| EPS (Diluted) | -$1.88-358.5% | -$0.30-25.0% | -$0.99-57.1% | -$1.44-157.1% | -$0.41+26.8% | -$0.24+56.4% | -$0.63-23.5% | -$0.56+16.4% |
| Diluted Shares (Avg) | 135M+44.7% | 130M+32.1% | N/A | 95M+39.4% | 93M+36.5% | 99M+53.6% | N/A | 68M+37.8% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.
CMPS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $504.6M+71.9% | $531.7M+66.6% | $210.3M-1.6% | $255.6M+3.3% | $293.5M+5.4% | $319.1M+3.3% | $213.7M-22.6% | $247.3M-17.3% |
| Current Assets | $475.7M+72.1% | $510.9M+67.2% | $191.5M-4.9% | $242.4M+3.7% | $276.4M+4.3% | $305.5M+3.4% | $201.3M-23.0% | $233.7M-18.0% |
| Cash & Equivalents | $433.3M+95.3% | $466.0M+79.2% | $149.6M-9.4% | $185.9M-10.2% | $221.9M-3.0% | $260.1M-1.1% | $165.1M-25.0% | $207.0M-16.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $420.0M+220.7% | $205.1M+65.8% | $263.2M+346.3% | $218.0M+301.4% | $131.0M+150.6% | $123.7M+148.2% | $59.0M+17.4% | $54.3M+18.6% |
| Current Liabilities | $367.3M+1072.4% | $153.8M+412.7% | $247.8M+628.5% | $197.4M+653.3% | $31.3M+42.2% | $30.0M+54.6% | $34.0M+73.5% | $26.2M+70.8% |
| Non-Current Liabilities | $52.7M-47.1% | $51.3M-45.3% | $15.4M-38.3% | $20.6M-26.8% | $99.7M+229.6% | $93.7M+207.8% | $25.0M-18.6% | $28.1M-7.7% |
| Long-Term Debt | $50.7M+121.0% | $50.5M+134.2% | $14.1M-42.8% | $18.6M-32.7% | $23.0M-22.0% | $21.6M-25.9% | $24.7M-14.3% | $27.6M-2.8% |
| Total Equity | $84.5M-48.0% | $326.7M+67.1% | -$52.8M-134.2% | $37.6M-80.5% | $162.6M-28.2% | $195.5M-24.6% | $154.7M-31.5% | $193.0M-23.8% |
| Retained Earnings | -$985.2M-66.7% | -$731.4M-32.4% | -$822.6M-53.8% | -$728.7M-48.3% | -$591.0M-30.5% | -$552.6M-33.2% | -$534.7M-40.9% | -$491.4M-41.6% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
CMPS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$40.3M-4.2% | -$47.9M-5.0% | -$37.8M+9.5% | -$35.1M-58.2% | -$38.7M-12.4% | -$45.7M-119.2% | -$41.8M-50.3% | -$22.2M-30.1% |
| Depreciation & Amortization | $0-100.0% | $0-100.0% | $6K-88.0% | $15K-74.6% | $158K | $37K-39.3% | $50K+149.0% | $59K-68.3% |
| Stock-Based Compensation | $4.0M+12.0% | $2.9M-26.4% | N/A | $3.2M-35.5% | $3.6M-26.9% | $3.9M-23.3% | N/A | $5.0M+11.8% |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$41.8M-50.3% | -$22.2M-29.9% |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0+100.0% |
| Financing Cash Flow | $7.6M+4453.6% | $362.5M+158.2% | $187K+20.6% | $0+100.0% | $166K-21.0% | $140.4M+121.0% | $155K+278.0% | -$53K-100.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CMPS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -300.2%-276.6pp | 27.9%+37.1pp | N/A | -366.4%-346.4pp | -23.6%-6.8pp | -9.1%+4.4pp | N/A | -20.0%-6.8pp |
| Return on Assets | -50.3%-37.2pp | 17.2%+22.8pp | N/A | -53.9%-38.3pp | -13.1%+0.6pp | -5.6%+5.8pp | N/A | -15.6%-4.4pp |
| Current Ratio | 1.30-7.5x | 3.32-6.9x | 0.77-5.1x | 1.23-7.7x | 8.82-3.2x | 10.18-5.0x | 5.92-7.4x | 8.91-9.6x |
| Debt-to-Equity | 0.60+0.5x | 0.150.0x | N/A | 0.49+0.4x | 0.140.0x | 0.110.0x | 0.160.0x | 0.140.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$52.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.77), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Compass Pathways Plc CMPS | FY2025 | N/A | -$269.8M | N/A | $1.8B | — |
| Nutex Health Inc NUTX | FY2025 | $875.3M | $70.8M | 8.1% | $1.3B | 80/100 |
| Sonida Senior Living Inc SNDA | FY2025 | $381.1M | -$72.5M | -19.0% | $1.8B | 47/100 |
| AUNA S.A. AUNA | FY2025 | N/A | N/A | N/A | $391.0M | — |
| Agilon Health Inc AGL | FY2025 | $5.9B | -$391.3M | -6.6% | $1.5B | 39/100 |
| Enhabit EHAB | FY2025 | $1.1B | -$4.6M | -0.4% | $706.9M | 29/100 |
Where Compass Pathways Plc Ranks
Frequently Asked Questions
Is Compass Pathways Plc profitable?
No, Compass Pathways Plc (CMPS) reported a net income of -$269.8M in fiscal year 2025.
What is Compass Pathways Plc's EBITDA?
Compass Pathways Plc (CMPS) had EBITDA of -$178.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Compass Pathways Plc have?
As of fiscal year 2025, Compass Pathways Plc (CMPS) had $149.6M in cash and equivalents against $14.1M in long-term debt.
What is Compass Pathways Plc's operating cash flow?
Compass Pathways Plc (CMPS) recorded an outflow of $157.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Compass Pathways Plc's total assets?
Compass Pathways Plc (CMPS) had $210.3M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Compass Pathways Plc spend on research and development?
Compass Pathways Plc (CMPS) invested $118.4M in research and development during fiscal year 2025.
What is Compass Pathways Plc's current ratio?
Compass Pathways Plc (CMPS) had a current ratio of 0.77 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Compass Pathways Plc's return on assets (ROA)?
Compass Pathways Plc (CMPS) had a return on assets of -128.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Compass Pathways Plc's P/E ratio?
Compass Pathways Plc (CMPS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $1.8B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Compass Pathways Plc's price-to-sales ratio?
Compass Pathways Plc (CMPS) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $1.8B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Compass Pathways Plc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Compass Pathways Plc (CMPS) held $149.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $157.2M over that year. Dividing the one by the other, the reported balance equals about 11 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Compass Pathways Plc's debt-to-equity ratio negative or not reported?
Compass Pathways Plc (CMPS) has negative shareholder equity of -$52.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Compass Pathways Plc's Piotroski F-Score?
Compass Pathways Plc (CMPS) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Compass Pathways Plc's earnings high quality?
Compass Pathways Plc (CMPS) reported a net loss of $269.8M while operations used $157.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Compass Pathways Plc cover its interest payments?
Compass Pathways Plc (CMPS) reported an operating loss of $179.0M against $4.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.